These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28935351)

  • 1. Impact of Left-Ventricular Assist Device-Related Complications on Posttransplant Graft Survival.
    Chauhan D; Okoh AK; Fugar S; Karanam R; Baran D; Zucker M; Camacho M; Russo MJ
    Ann Thorac Surg; 2017 Dec; 104(6):1947-1952. PubMed ID: 28935351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart transplantation outcomes in patients with continuous-flow left ventricular assist device-related complications.
    Quader MA; Wolfe LG; Kasirajan V
    J Heart Lung Transplant; 2015 Jan; 34(1):75-81. PubMed ID: 25150620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Continuous-Flow Left Ventricular Assist Device Duration on Postoperative Outcomes.
    Chauhan D; Okoh AK; Haik N; Kang N; Choi M; Baran D; Zucker M; Camacho M; Russo MJ
    Ann Thorac Surg; 2017 Dec; 104(6):1933-1938. PubMed ID: 28964413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Systemic and Device-Related Complications in Patients Bridged to Transplantation With Left Ventricular Assist Devices.
    Lui C; Suarez-Pierre A; Zhou X; Crawford TC; Fraser CD; Giuliano K; Hsu S; Higgins RS; Zehr KJ; Whitman GJ; Choi CW; Kilic A
    J Surg Res; 2020 Feb; 246():207-212. PubMed ID: 31605947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database.
    Healy AH; Baird BC; Drakos SG; Stehlik J; Selzman CH
    Ann Thorac Surg; 2013 Mar; 95(3):870-5. PubMed ID: 23218024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporary left ventricular assist devices as a bridge to heart transplantation.
    Seese L; Hickey G; Keebler ME; Mathier MA; Sultan I; Gleason TG; Wang Y; Kilic A
    J Card Surg; 2020 Apr; 35(4):810-817. PubMed ID: 32092194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttransplant survival is not diminished in heart transplant recipients bridged with implantable left ventricular assist devices.
    Russo MJ; Hong KN; Davies RR; Chen JM; Sorabella RA; Ascheim DD; Williams MR; Gelijns AC; Stewart AS; Argenziano M; Naka Y
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1425-32.e1-3. PubMed ID: 19931672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation.
    Fudim M; Davis ME; Jenkins C; Brown CL; Wigger MA; Stulak JM; Maltais S; Haglund N
    Ann Thorac Surg; 2015 Dec; 100(6):2117-25; discussion 2125-6. PubMed ID: 26338051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged continuous-flow left ventricular assist device support and posttransplantation outcomes: A new challenge.
    Fukuhara S; Takeda K; Polanco AR; Takayama H; Naka Y
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):872-880.e5. PubMed ID: 26896362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Status 1A Heart Transplantation Survival in the Continuous Flow Left Ventricular Assist Device Era.
    Trivedi JR; Rajagopal K; Schumer EM; Birks EJ; Lenneman A; Cheng A; Slaughter MS
    Ann Thorac Surg; 2016 Nov; 102(5):1512-1516. PubMed ID: 27329191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does renal dysfunction and method of bridging support influence heart transplant graft survival?
    Haglund NA; Feurer ID; Dwyer JP; Stulak JM; DiSalvo TG; Keebler ME; Schlendorf KH; Wigger MA; Maltais S
    Ann Thorac Surg; 2014 Sep; 98(3):835-41. PubMed ID: 25069689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of 30-day post-transplant mortality in patients bridged to transplantation with continuous-flow left ventricular assist devices--An analysis of the International Society for Heart and Lung Transplantation Transplant Registry.
    Healy AH; Stehlik J; Edwards LB; McKellar SH; Drakos SG; Selzman CH
    J Heart Lung Transplant; 2016 Jan; 35(1):34-39. PubMed ID: 26296960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support.
    Takeda K; Takayama H; Kalesan B; Uriel N; Colombo PC; Jorde UP; Yuzefpolskaya M; Mancini DM; Naka Y
    J Heart Lung Transplant; 2015 Jan; 34(1):89-99. PubMed ID: 25444372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of left ventricular assist device bridging on posttransplant outcomes.
    Pal JD; Piacentino V; Cuevas AD; Depp T; Daneshmand MA; Hernandez AF; Felker GM; Lodge AJ; Rogers JG; Milano CA
    Ann Thorac Surg; 2009 Nov; 88(5):1457-61; discussion 1461. PubMed ID: 19853092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do Patients Supported With Continuous-flow Left Ventricular Assist Device Have a Sufficient Risk of Death to Justify a Priority Allocation? A Propensity Score Matched Analysis of Patients Listed in UNOS Status 2.
    Mastrobuoni S; Dell'Aquila AM; Van Caenegem O; Poncelet A; Jacquet LM; Garcia J
    Transplantation; 2018 Jun; 102(6):e288-e294. PubMed ID: 29346259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of infection among left ventricular assist device recipients on post-transplantation outcomes: A retrospective review.
    Lerman DT; Hamilton KW; Byrne D; Lee DF; Zeitler K; Claridge T; Gray J; Minamoto GY
    Transpl Infect Dis; 2018 Dec; 20(6):e12995. PubMed ID: 30199584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality.
    Donneyong M; Cheng A; Trivedi JR; Schumer E; McCants KC; Birks EJ; Slaughter MS
    ASAIO J; 2014; 60(3):294-9. PubMed ID: 24614355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.